Microbion
is a Montana-based pharmaceutical company that develops and commercializes novel medicines for the treatment of chronic and antibiotic-resistant infections... Read moreMicrobion
is a Montana-based pharmaceutical company that develops and commercializes novel medicines for the treatment of chronic and antibiotic-resistant infections... Read more
News
Nov 14, 2024
Clinical Trials Arena
Microbion: Microbion reports topline data from Phase II study of DFI therapy
Apr 25, 2024
Cision Canada
Press Release: Microbion : Microbion Receives Award at Advanced Wound Care Summit USA's Innovation Showcase
Apr 15, 2024
StreetInsider
Press Release: Microbion : Microbion Selected to Present at Advanced Wound Care Summit USA
Apr 04, 2024
PR Newswire
Microbion: Microbion's Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal
Feb 01, 2024
OINDPnews
Microbion: Microbion's pravibismane gets orphan drug designation for NTM indication
Oct 05, 2023
StreetInsider
Press Release: Microbion : Microbion CEO to Participate in Panel Discussion at BioFuture 2023
Aug 15, 2023
PR Newswire
Press Release: Microbion : Microbion Presented New Pravibismane Data Against Mycobacteroides abscessus at the 6th World Bronchiectasis and NTM Conference
Aug 14, 2023
PR Newswire
Press Release: Microbion : Microbion to Present Design of Ongoing Phase 2 Study Treating Diabetic Foot Ulcer Infections at the 2023 Military Health System Research Symposium
Jun 16, 2023
Cision Canada
Press Release: Microbion : Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics at ASM Microbe 2023
May 10, 2023
PR Newswire
Press Release: Microbion : Microbion Corp. Presents a Poster on Pravibismane's Activity Against Diabetic Foot Infection Patient Isolates
Microbion Competitors
1
2
3
4
5
6
7
8
9
10